Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss linked to higher heart disease risk in both men and women.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Finasteride effectively treats hair loss in transgender men with few side effects.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

There is no significant link between male pattern baldness and insulin resistance.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.